Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lawrence W. Wu
Author Correction: PAK Signalling Drives Acquired Drug Resistance to MAPK Inhibitors in BRAF-mutant Melanomas
Nature
Multidisciplinary
Related publications
PAK Signaling Promotes Acquired Resistance to BRAF and MEK Inhibitors
Cancer Discovery
Oncology
Correction: ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma
Cancer Discovery
Oncology
Acquired Resistance to BRAF Inhibition in BRAFV600E Mutant Gliomas
Oncotarget
Oncology
Molecular Landscape of Acquired Resistance to Targeted Therapy Combinations in BRAF-Mutant Colorectal Cancer
Cancer Research
Cancer Research
Oncology
mTORC1/autophagy-regulated MerTK in Mutant BRAFV600 Melanoma With Acquired Resistance to BRAF Inhibition
Oncotarget
Oncology
Acquired Resistance to BRAF Inhibition Can Confer Cross-Resistance to Combined BRAF/MEK Inhibition
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-mutant Melanoma
Cancer Research
Cancer Research
Oncology
LB993 Focal Adhesions Mediate Rac1 P29S -Dependent Drug Resistance to MAPK Inhibitors in Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Inhibitors of Pan-Pi3k Signaling Synergize With BRAF or MEK Inhibitors to Prevent BRAF-Mutant Melanoma Cell Growth
Frontiers in Oncology
Cancer Research
Oncology